Aetiology of premature ovarian failure

Menopause International

Volumn 15, Issue 2, 2009, Pages 72-75

  Vujovic, Svetlana ^a  

^a CLINICAL CENTER OF SERBIA   (Serbia)

Author keywords

aetiology; ovarian damage; Premature ovarian failure

Indexed keywords

AUTOANTIBODY;

AIRE GENE; APOPTOSIS; ATRESIA; B LYMPHOCYTE; CELL ACTIVITY; CELL COUNT; CHICKENPOX; CHROMOSOME TRANSLOCATION; CYTOMEGALOVIRUS INFECTION; CYTOTOXIC LYMPHOCYTE; DOMINANT GENE; ENVIRONMENTAL FACTOR; FRAGILE X SYNDROME; GALACTOSEMIA; GENE DELETION; GENE DOSAGE; GENE MUTATION; GENE SILENCING; GENE TRANSLOCATION; HERPES SIMPLEX; HUMAN; MALARIA; MEIOSIS; MENTAL DEFICIENCY; MONOSOMY; NATURAL KILLER CELL; OVARY DISEASE; OVARY FOLLICLE; OVARY FOLLICLE MATURATION; OVARY INFLAMMATION; PREMATURE OVARIAN FAILURE; REVIEW; SHIGELLOSIS; T LYMPHOCYTE SUBPOPULATION; TRISOMY; TUBERCULOSIS; TURNER SYNDROME;

CHROMOSOME ABERRATIONS; CHROMOSOMES, HUMAN, X; FEMALE; FRAGILE X MENTAL RETARDATION PROTEIN; HUMANS; INFERTILITY, FEMALE; OVARIAN FAILURE, PREMATURE; PHOSPHOTRANSFERASES (PHOSPHOMUTASES);

EID: 67649970424     PISSN: 17540453     EISSN: 17540461     Source Type: Journal    
DOI: 10.1258/mi.2009.009020     Document Type: Review

References (26)

1. Beck-Peccoz P, Persani L. Premature ovarian failure. Orphanet Encyclopedia, October 2005
2. Conway GS. Clinical manifestations of genetic defects affecting gonadotrophins and their receptors. Clin Endocrinol (Oxford) 1996; 45: 657–63
3. Van Kesteren YM, Hundscheid RD, Smits AP, Cremers FP, van Zonneveld P, Braat DD. Familial idiopathic premature ovarian failure: an overrated and underestimated genetic disease? Hum Reprod 1999; 14: 2455–9
4. Vegetti W, Marozzi A, Manfredini E, Teasta G, Alagna F, Nicolosi A. Premature ovarian failure. Mol Cell Endocrinol 2000; 161: 53–57
5. Snowdon DA, Kane RL, Beeson WL,, et al. Is early natural menopause a biological marker of healthy aging? Am J Public Health 1989; 79: 709–14
6. Schlessinger D, Herrera L, Mumm S, Percesepe A, Pellegrini M, Pilia G. Genes and translocations involved in premature ovarian failure. Am J Med Genet 2002; 111: 328–33
7. Davis CJ, Davison RM, Payne NN, Rodeck CH, Conway GS. Female sex preponderance for idiopathic familial premature ovarian failure suggests an X chromosome deficiency: opinion. Hum Reprod 2000; 15: 2418–22
8. Loughlin SA, Redha A, McIver J, Boyd E, Carothers A, Connor JM. Analysis of the origin of Turner syndrome using polymorphic DNA probes. J Med Genet 1991; 28: 156–158
9. Jacobs P, Baikie AG, Brown WM, Mac Gregor TN, Maclean N, Harnden DG. Evidence for the existence of the human super female. Lancet 1959; 274: 423–425
10. Merry DE, Lesko JG, Sosnoski DM,, et al. Choroideremia and deafness with stapes fixation: a contiguous gene deletion syndrome in Xq21. Am J Hum Genet 1989; 45: 530–40
11. Sarto GE, Therman E, Pataw K. X inactivation in man: a woman with t (Xq−12q+). Am J Hum Genet 1973; 25: 262–70
12. Therman E, Laxova R, Susman B. The critical region on the human Xq. Hum Genet 1990; 85: 455–61
13. Tharapel AT, Anderson KP, Simpson JL, Martens PR, Wilroy RS, Schwartz CE. Deletion (X) (q26.1–128) in proband and her mother: molecular characterization and phenotypic karyotypic deductions. Am J Hum Genet 1993; 52: 463–71
14. Powell CM, Taggart RT, Drumheller TC,, et al. Molecular and cytogenetic studies of an X: autosome translocations in patients with premature ovarian failure and review of the literature. Am J Med Genet 1994; 52: 19–26
15. Krauss CM, Turksoy RN, Atkins L, Mc Laughlin C, Brown LG, Page DC. Familial premature ovarian failure due to an interstitial deletion of the long arm of the X chromosome. N Engl J Med 1987; 317: 125–31
16. Marozzi A, Testa G, Cinelli E, Menevri R, Dal PRA. Association between idiopathic premature ovarian failure and fragile X mutation. Hum Reprod 2000; 15: 197–202
17. Murray A. Premature ovarian failure and FMR1 gene. Semin Reprod Med 2000; 18: 59–66
18. Sedmak DD, Hart WR, Tubbs RR. Autoimmune oophoritis: a histologic study of involved ovaries with immunologic characterisation of the mononuclear cell infiltrate. Int J Gynecol Pathol 1987; 6: 73–81
19. Hoek A, Schomaker J, Drexhage A. Premature ovarian failure and ovarian autoimmunity. Endocr Rev 1997; 18: 17–134
20. Pekonen F, Siegberg R, Makinen T, Miettinen A, Yli-Korkala O. Immunological disturbances in patients with premature ovarian failure. Clin Endocrinol 1986; 25: 16–26
21. Hoek A, van Kesteren Y, Haan-Meulman M, Hooijkaas H, Schoemaker J, Drexlage HA. Analysis of peripheral blood lymphocyte subunits, NK cells and delayed type hypersensibility skin test in patients with premature ovarian failure. Am J Reprod Immunol 1995; 33: 495–502
22. Belvisi L, Bombelli F, Sironi L, Doldi N. Organ-specific autoimmunity in patients with premature ovarian failure. J Endocrinol Invest 1993; 16: 889–92
23. Bakalov VK, Vanderhoof UH, Bondy CA, Nelson LM. Adrenal antibodies detect asymptomatic auto-immune adrenal insufficiency in young women with spontaneous premature ovarian failure. Hum Reprod 2002; 17: 2096–100
24. Rees M. Various management strategies for problems encountered during menopause. Menopause Int 2008; 14: 93
25. Goswami D, Conway GS. Premature ovarian failure. Horm Res 2007; 68: 196–202
26. Forges T, Monnier-Barbarino P. Premature ovarian failure in galactosaemia: pathophysiology and clinical management. Pathol Biol 2003; 51: 47–56